SCHEMBL30976326

SCHEMBL30976326

Cc1ccncc1N1CCN(C(=O)c2nn(C(C)C)c(=O)c3ccccc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.57
▸ LMNA P02545 4/20 0.57
▸ GAA P10253 4/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ MEN1 O00255 1/20 0.45
▸ MAPT P10636 5/20 0.44
▸ TP53 P04637 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ HTT P42858 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31199155 0.84 ALDH1A1 (0.56) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976308 0.84 ALDH1A1 (0.59) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976303 0.82 ALDH1A1 (0.56) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976246 0.80 NPSR1 (0.76) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL31199102 0.78 ALDH1A1 (0.55) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976420 0.78 ALDH1A1 (0.56) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL31199213 0.78 ALDH1A1 (0.55) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976487 0.78 ALDH1A1 (0.57) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976301 0.77 ALDH1A1 (0.53) ALDH1A1LMNAGAANPSR1KMT2A
SCHEMBL30976368 0.76 HTT (0.61) ALDH1A1LMNAGAANPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback